News Guizhou Yibai Pharmaceutical Co., Ltd.

Stocks

600594

CNE000001H03

Pharmaceuticals

End-of-day quote Shanghai S.E. 2026-09-03			5-day change	1st Jan Change
3.790 ^CNY	-4.53%		-7.11%	-4.77%

08-20	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-22	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

All News

Mentions Relevance

08-20	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-22	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
25-10-29	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-09-18	Authorities Lift Suspension Order on Yibai Pharma's Production, Sales of Children's Cough Syrup	MT
25-08-20	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-08-06	Yibai Pharmaceutical Gets Order to Suspend Marketing of Children's Cough Syrup	MT
25-04-25	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
24-11-27	Guizhou Yibai Pharmaceutical Co., Ltd. 's Equity Buyback announced on November 29, 2023 has expired.	CI
24-10-25	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
24-10-09	Tranche Update on Guizhou Yibai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 30, 2023.	CI
24-09-09	Guizhou Yibai Pharmaceutical CFO Steps Down; Successor Named	MT
24-09-04	Guizhou Yibai Pharmaceutical Gets China Approval for Multiple, Non-Hodgkin's Lymphoma Drug	MT
24-08-23	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-07-02	Tranche Update on Guizhou Yibai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 30, 2023.	CI
24-04-18	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
23-11-29	Guizhou Yibai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	CI
23-11-28	Guizhou Yibai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	CI
23-10-26	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
23-08-17	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-04-27	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-04-27	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-01-25	GuiZhou YiBai Pharma to Book 2022 Loss on Policy Changes, COVID-19	MT
22-11-24	Guizhou Yibai Pharmaceutical Completes Construction of $84.5 Million Factory	MT
22-10-27	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	CI
22-08-25	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	CI